Skip to main content

Functional neurosurgery · UK

Focused ultrasound thalamotomy - consultant-led, done properly.

Incisionless MR-guided focused ultrasound (MRgFUS) thalamotomy for essential tremor and tremor-dominant Parkinson’s - a single-session, no-implant alternative to DBS for the right patient.

A stethoscope on a clinical desk

Indicative pricing

What private focused ultrasound thalamotomy costs in the UK.

Indicative ranges across private UK providers.

In short

£25,000–£40,000, home the same day.

Option Indicative range
Movement-disorders consultant assessment £400–£750
MRgFUS suitability MDT (imaging + neurology + neurosurgery) £1,500–£3,000
Preoperative CT and skull-density review £450–£900
MRgFUS unilateral thalamotomy (single session) £25,000–£40,000
Follow-up neurology visit (6 weeks) £300–£500
Second-side procedure (staged, if offered) £25,000–£40,000

Prices vary by clinic, by the consultant’s seniority, and by whether combinations are used.

The problem

An incisionless single-session option, in a very selected group.

MRgFUS is a genuine advance for the right patient - unilateral, medication-refractory tremor with a favourable skull. It is a poor match for everyone else.

  • Consultant, not delegated

    The consultant who assessed you should be the consultant who treats you - not a junior on a busy list.

  • Evidence, not sales

    The recommendation is what fits your clinical picture - not what the clinic wants to sell you today.

  • Written pathway, not verbal promise

    The plan, the prices and the follow-up are in writing before you commit - not surfaced when the invoice arrives.

Who it suits

When MRgFUS is the right choice over DBS.

The tremor patients who may be suited to focused ultrasound - and when DBS is the better option instead.

  • You have thought about this for a while

    Not an impulse - a decision you have carried and want to act on properly.

  • You want the right treatment, not the fastest

    You want to be seen by a consultant who does this every week, not the next available diary slot.

  • You have tried the obvious first steps

    GP care, over-the-counter routes, or first-line therapy - and the problem is still there.

  • You are otherwise well enough to proceed

    Stable on medication, not acutely unwell, not in a flare that would postpone treatment.

  • You are willing to follow the plan

    Attend the follow-up, take the medicines, do the physio - whichever this treatment needs to work.

  • You are prepared for the recovery

    You have thought about time off work, help at home and - where relevant - the cost of ongoing care.

  • You want a named consultant, not a rotating list

    The person who assesses you should be the person who treats you and reviews you afterwards.

  • Red flag: you were declined elsewhere and want to override that

    If another consultant has said no on medical grounds, that advice should not be worked around. Ask them to explain why.

Options

Unilateral thalamotomy - with or without a later second side.

What one side achieves, and why a second side is not always offered.

  • Assessment and shared decision

    A full consultant hour and honest expectations conversation - the difference between a treatment that suits you and one that only suits the clinic.

  • First-line treatment

    What most patients start with, and what most get on with well.

  • Course-based or staged treatments

    Some treatments deliver over three to six visits or in stages.

  • Combined modality

    The strongest outcomes often come from combining approaches - medical, procedural and behavioural. Good plans are made across the year, not the visit.

  • Maintenance

    Most conditions need ongoing care after the initial treatment. It helps to have this built into the plan up front so you know the real commitment.

  • Alternatives to consider

    Where a different treatment might suit better, it should be discussed - including newer or older options that the marketing does not push.

  • Escalation pathway

    What happens if this treatment does not work - the next option, in writing, before you start.

  • When to say no or refer

    For patients who fall outside criteria, the usual approach is referral to the right specialist or back to NHS care rather than treatment regardless.

Safety and recovery

What to expect afterwards - honestly.

Consultant-led private care is generally low-risk. The things worth planning are candidacy, dose or intensity, downtime and what happens if something is not right.

  • A named UK consultant, in a CQC-regulated setting

    The consultant who assessed you should be the consultant who treats you. That single change removes most of the common safety problems.

  • Realistic outcomes, spelled out

    What this treatment can and cannot do - and what happens if it does not work. If you are hoping for something this treatment cannot deliver, a good clinic says so before you book.

  • Written pre-care and aftercare

    What to do before, on the day, and after - including medication changes, contraindications and warning signs. In writing and by message, not verbally in a corridor.

  • Rare but serious risks

    Every treatment has its own list. The consultant discusses them at consent - not glossed, not exaggerated. You take those notes home.

  • Contraindications matter

    Pregnancy, active infection, uncontrolled cardiovascular disease, immunosuppression, bleeding tendency and drug interactions - all reasons to postpone. A clinic should ask about each of these.

  • A same-day contact number

    Written aftercare plus a phone number that answers on the day. Complications improve dramatically with early intervention, and hard to reach clinics cost lives.

  • Included follow-up

    The review appointment is booked before you leave - included in the pathway price, not billed separately when something is not right.

  • Escalation to hospital where needed

    Any private pathway has to have a plan for when things escalate - which hospital, which team, and how to get there.

  • Written record and second opinion

    You leave with the record, the images and the plan - enough for another consultant to pick up if you ever want a second opinion.

Reading your treatment record

Your treatment record in four parts. Read the last one first.

Whichever pathway you chose, the record the clinic sends you keeps to the same shape.

A consultant reviewing a treatment record

A quiet reminder

Keep every note, batch and image on file - it matters if you ever need a second opinion.

If you have a record from another clinic, take it with you to your next visit.

  1. 01 Assessment

    What was recommended and why

    The consultant’s written note - history, examination, differential and the plan agreed with you. Read this alongside the pathway.

  2. 02 Procedure / Treatment

    What was actually done

    The named procedure, materials, medicines and settings used. Keep this - it matters for future care and for any second opinion.

  3. 03 Findings

    What was found or measured

    Any pathology, imaging or intra-procedural findings. Written in plain English alongside the technical terms.

  4. 04 Plan

    Follow-up, medication, warning signs

    Read this first: when to come back, medication changes, what is normal, and what needs a same-day phone call.

Recognised by major UK insurers

BupaAXA HealthVitalityAvivaWPACignaHealixBupaAXA HealthVitalityAvivaWPACignaHealixBupaAXA HealthVitalityAvivaWPACignaHealix

Insurance cover for this pathway varies by policy - some elements may be covered, others self-pay. Where NHS provision exists but is delayed, private care is the practical route.

Frequently asked

Common questions about focused ultrasound thalamotomy.

Quick answers on candidacy, safety, cost and outcomes.

  • Is focused ultrasound available on the NHS?

    At a small number of specialist centres for a narrow set of indications - essential tremor and, more recently, tremor-dominant Parkinson’s. NHS commissioning criteria are strict and waits can be long; private access is often the practical route.

  • How is this different from DBS?

    MRgFUS is a single-session, incisionless procedure with no implanted hardware. It makes a permanent lesion in the thalamus and cannot be reversed or dialled up like DBS. It is well-suited to unilateral tremor in one arm; DBS is preferred when both sides need long-term programmable control.

  • What does private MRgFUS cost in the UK?

    Roughly £25,000–£40,000 for the single-session unilateral thalamotomy, plus assessment and follow-up. A staged contralateral procedure (rarely offered) would be similar again 12+ months later, in centres willing to do it.

  • Am I suitable?

    You need a specific skull density index (measured on CT), a treatable tremor that has failed medication, and no significant cognitive impairment. Around 60–70% of tremor patients referred are technically suitable; the MDT decides.

  • What are the risks?

    Gait unsteadiness, numbness or paraesthesia in the treated hand or face, dysarthria - most transient, some persistent in a minority. No open surgery risks (haemorrhage, infection) because there is no incision.

  • How quickly does tremor improve?

    Immediately - patients often see their hand still on the treatment table. Improvement is typically 60–90% in the treated arm; the untreated arm is unchanged.

Related treatments

Looking for something else?